PhD in Physiology and Pharmacology (UNSW), 2016
BVSc (Hons), 2008
I am a Researcher/Lecturer working with the Pancreatic Research Group, South West Sydney Clinical Campuses/Ingham Institute, Liverpool. My current research focuses on early detection of pancreatic cancer through identification of possible biomarkers. This will be achieved by using in-vitro and in-vivo models of pancreatic cancer as well as 'omic' techniques to identify potential factors in small extracellular vesicles derived from pancreatic cancer and stellate cells. Once identified, the presence of lead candidate biomarkers will be tested in patients with new-onset diabetes/pancreatic cancer-related diabetes, which is now considered to be a group at 'high risk' of developing pancreatic cancer.
Prior to joining the field of Pancreatic Research, I worked in the field of Neuroscience, where I completed my PhD in the field of Neuropathic pain in 2016 from School of Medical Sciences, UNSW Medicine. During my PhD, I investigated immune-modulatory approaches for the treatment of neuropathic pain in animal models. Then, in my first post-doctoral years, I worked in the Sensori-Motor Physiology and Therapeutics (SMPT) group in the Translational Neuroscience Facility, where I aimed to identify a potential neuroprotective compound to reduce excitotoxicity following traumatic brain injury.
NHMRC Ideas Grant (2020-2024) - Pancreatic Cancer Related Diabetes (PCRD) - Novel role of Pancreatic Stellate Cells
CONCERT seed grant (2020-2022) - Pancreatic cancer related diabetes-Elucidating its mechanism to enable diagnosis and improved treatment of pancreatic cancer
PanKind Early detection innovation grant (2022) - Deciphering the Exosomal RNA Cargo in Pancreatic Cancer-related diabetes using Transcriptmonics: A Novel Approach for Early Detection of pancreatic cancer
I. Effects of exosomes derived from pancreatic stellate and cancer cells on islet cell dysfunction
II. Effects of exosomes derived from pancreatic stellate and cancer cells on insulin signalling
III. Effects of High Fructose Diet on impaired glucose tolerance/pre-diabetes and cancer progression in transgenic mouse model of pancreatic cancer
IV. Identification of protein, RNA, lipid and metabolic biomarkers in extracellular vesicular cargo using 'omic' techniques
V. Identification of possible candidate biomarkers of pancreatic cancer
I. Founder - Ingham Institute Public Speaking Club
II. Deputy Chair - Ingham Institute Postdoc Association
III. Committee member - MedECAN
IV. Member of Gastroenterological Society of Australia
V. Member of American Pancreatic Association
VI. Member of American Gastroenterological Association
VII. Member of International Society of Extracellular Vesicles
VIII. Member of Australian Pancreatic Club
IX. Mentor - UNSW Alumni Career Discovery Mentoring Program
My Research Supervision
Honours and PhD students
Currently, I facilitate Medicine Phase 1 Scenario Groups (Ageing & Ending).
I have experience in teaching Anatomy, Physiology, Immunology, Microbiology and Biology for Medical, Medical Science and Science students.